OptimizeRx Corp Quarterly Income Tax Expense (Benefit) in USD from Q2 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
OptimizeRx Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2023 to Q3 2024.
  • OptimizeRx Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$817K.
  • OptimizeRx Corp annual Income Tax Expense (Benefit) for 2023 was -$7.6M.
  • OptimizeRx Corp annual Income Tax Expense (Benefit) for 2019 was -$898K.
  • OptimizeRx Corp annual Income Tax Expense (Benefit) for 2015 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$817K Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$1.09M -$1.12M -3397% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-15
Q1 2024 $344K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q2 2023 $33K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.